High Throughput Process Development Market Trends [2031]

Report Description

High Throughput Process Development Market Outlook 2031

The global high throughput process development market size was USD 477 Million in 2022 and is likely to reach USD 1,600 Million by 2031, expanding at a CAGR of 14.5% during 2023–2031. The market growth is attributed to the rising usage of miniature bioreactors.

High usage of miniature bioreactors to develop a high throughput process is anticipated to fuel the high throughput process development (HTPD) market. These bioreactors allow parallel processing of several experiments, which enables researchers to quickly screen and optimize several conditions in a resource-efficient manner. The high throughput nature of miniature bioreactors increases the development and scalable processes in the field of biopharmaceutical manufacturing, which boosts the market.

• In September 2023, Waters Corporation launched a new bioprocess walk-up solution that is designed to streamline biologic sample prep and analysis. The new solutions make it easier to increase upstream bioprocess development by up to six weeks over traditional methods, by reducing the need to send bioreactor samples to a central laboratory for analysis.

Get Free Sample Report

The market report finds that the COVID-19 pandemic hindered the high throughput process development market, owing to the strict regulations imposed by the government. Business shutdowns, social distancing, and travel bans affected the market. However, a prolonged shutdown of various industries affected the supply chain and significantly impacted the delivery schedules, manufacturing, and sales of the products, which hampered the market.

Impact of Artificial Intelligence in High Throughput Process Development Market

Artificial intelligence (AI) technologies are anticipated to fuel the high throughput process development market during the forecast period. AI is used to help focus, direct, and reduce screening efforts by using soft sensors, in-silico models, and data mining approaches such as quantitative structure-activity relationship (QSAR), multivariate data analysis (MDVA), and mechanistic modeling. AI is used to help optimize the HTPD process by reducing screening efforts and predicting outcomes, which leads to faster and more efficient drug discovery and development.

High Throughput Process Development Market Dynamics

Get Free Sample Report

Major Drivers

Increasing need to identify new drug targets is projected to drive the HTPD market. The importance of target discovery is propelled by the continued exploration of novel therapeutic options and the desire to address unmet medical needs. High throughput methods allow the screening of large numbers of potential targets, which helps in the identification of promising candidates for drug development.

Existing Restraints

Lack of adequate infrastructural facilities and the high cost of technology hampers the high throughput process development market. Restrictions in data management resources, automation systems, and specialized equipment affect the market. However, the implementation of advanced automation and specialization contributes to increased expenses, as it is significant to balance innovation and cost-effectiveness to ensure the sustainability of these processes in drug discovery and other scientific applications, which hinders the market.

Emerging Opportunities

Increasing research & development for drug discovery is expected to create immense opportunities in the high throughput process development (HTPD) market. Advancements in data analysis, automation, and advanced technologies accelerate the optimization and identification of potential drug applicants, which increases efficiency and reduces the cost and time that is involved in the drug discovery pipeline.

• In February 2023, Carterra Inc. introduced its latest HT-SPR instrument, the LSA, at the Society for Laboratory Automation and Screening (SLAS) conference and exhibition in San Deigo, CA. This new instrument brings augmented sensitivity to Caterra’s highly successful LSA platform, which enables additional applications throughout drug discovery and the development at throughput levels unseen in any other instrument.

Scope of High Throughput Process Development Market Report

The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

High Throughput Process Development Market Segment Insights

Product and Service Segment Analysis

Based on product and service, the high throughput process development market is divided into instruments, consumables, software, and services. The instruments segment is further bifurcated into automated miniature bioreactor system and automatic integrated workstation. The consumables segment is further segregated into micro-well filter plates, micropipettes and pipette tips, miniature prepacked columns, and others.

The consumables segment is expected to expand at a significant pace during the projection period, owing to the presence of a wide variety of reagents and continuous product research and development in consumables. The usage of consumables is an integral part of HTPD. Consumables such as disposable labware, assay, and reagents & kits are often used, as they increase efficacy by reducing the risk of contamination and streamlining workflows that allow similar processing.

Get Free Sample Report

Technology Segment Analysis

In terms of technology, the global market is segregated into ultraviolet-visible spectroscopy, chromatography, and others. The chromatography segment is further classified into ion exchange, affinity chromatography, multi-modal chromatography, and others.

The chromatography segment is projected to register a considerable CAGR during the forecast period, due to the increasing benefits of affinity chromatography, such as high flow rate and specificity. The high throughput process development (HTPD) platform offers a systematic approach for time and resource-efficient chromatography process development. HTPD allows quick checking of chromatographic conditions. Verification is performed with large columns after scouting and screening.

Molecular Type Segment Analysis

On the basis of molecular type, the high throughput process development market is segmented into monoclonal antibodies, polysaccharide vaccines, and others. The monoclonal antibodies segment is expected to register a robust growth rate during the forecast period, owing to the increasing use of targeted immunotherapy along with growth in the number of therapeutic monoclonal antibodies (MAbs) that are approved by the FDA. MAbs are driven by the development of the multibillion-dollar biotechnology industry and several pharmaceutical companies that entered into the MABs sector, which is attracted by less and quick costly development, premium pricing, high success rates, and potentially reduced threats from generics.

• In September 2023, KBI Biopharma launched SUREmAb, an offering built on the robustness of KBI’s SUREtechnology platform that allows for safe, optimized, and cost-efficient mAb manufacturing and development. It is a vertically integrated global offering that is designed to lessen development timelines for global biopharmaceutical manufacturers, providing research cell bank (RCB) development in as little as 9 weeks and the capability for customers to move from DNA to GMP drug substance in as few as 11 months.

Get Free Sample Report

End-user Segment Analysis

Based on end-user, the global market is segregated into contract research organizations, biotechnology and biopharmaceutical companies, and others. The biotechnology and biopharmaceutical companies segment is anticipated to hold a key share of the market in the coming years, owing to the increasing research & development investments to accelerate drug manufacturing. The segment growth is further attributed to the high pressure from regulatory authorities to reduce the cost of HTPD. Increasing technological advancements in the fields of drug development and strategic developments by key players boost the segment.

• In November 2022, Mission Bio collaborated with AVROBIO’s lysosomal disorder pipeline, to develop a precise, reproducible assay by using the Tapestri Platform of Mission Bio to rapidly measure the percentage of transduced cells in samples composed of thousands of cells.

Regional Analysis

In terms of region, the global high throughput process development market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to the easy availability of advanced technological products. High demand for reducing product development timelines and increasing demand for technologically advanced tools for improving the production quality of biological materials create potential opportunities in the market. The regional market growth is further attributed to the increasing research and development activities, well-established healthcare infrastructure, and increasing prevalence of chronic diseases in the region.

The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, owing to the increasing healthcare expenditures. The regional market growth is further attributed to the increasing use of several HPTD methodologies, such as process optimization and scale-up studies. Increasing biotechnology and biopharmaceutical industries and increasing research & development activities in the region are anticipated to boost the market.

Get Free Sample Report